Funding Received
$70.2 Million in 2 Rounds from 6 Investors
Most Recent Funding
$39.9 Million Series B on October 3, 2013
Founded:
2003
Headquarters:
Utrecht
Description:
Merus is a biomedical company engaged in the discovery and development of antibody-based biopharmaceuticals.
Categories:
Biotechnology
Website:
http://www.merus.nl

Detailed Description

Update

Merus B.V., a biomedical company, engages in the discovery and development of antibody-based biopharmaceuticals. It develops Oligoclonics technology that offers a class of human antibodies, called Oligoclonics. Oligoclonics is a concept whereby a mixture of various human therapeutic antibodies, directed to a common antigen are produced from a single cell clone. The company was founded in 2003 and is based in Driebergen, the Netherlands.

Past Team (1)

Update

Board Members and Advisors (2)

Update

Investors (5)

Update

Offices/Locations (1)

Update
  • Office

    Padualaan 8 (postvak 133)

    Utrecht, 3584 CH

    NLD

Images (1)

Update
  • F81c924f5e540bbcd9f024ddfc368665